نتائج البحث - "citrullinated protein antibodies"

Relation: info:eu-repo/semantics/altIdentifier/pmid/38092030; info:eu-repo/semantics/altIdentifier/eissn/1462-0332; https://serval.unil.ch/notice/serval:BIB_42DABD0BE29B

الاتاحة: https://serval.unil.ch/notice/serval:BIB_42DABD0BE29B
https://doi.org/10.1093/rheumatology/kead682

View record in BASE

10

Academic Journal

Rheumatoid arthritis as a clinical and immunological syndrome: focus on the seronegative subtype of the disease

المؤلفون: E. L. Nasonov, A. S. Avdeeva, D. A. Dibrov

المصدر: Научно-практическая ревматология, Vol 61, Iss 3, Pp 276-291 (2023)

مصطلحات موضوعية: rheumatoid arthritis seropositive rheumatoid arthritis, seronegative rheumatoid arthritis, rheumatoid factor, anti-citrullinated protein antibodies, new autoantibodies in rheumatoid arthritis, Diseases of the musculoskeletal system, RC925-935

وصف الملف: electronic resource

Relation: https://rsp.mediar-press.net/rsp/article/view/3355; https://doaj.org/toc/1995-4484; https://doaj.org/toc/1995-4492

URL الوصول: https://doaj.org/article/689e53bdd93045eeb071c668ef028f20

View record in DOAJ

11

Academic Journal

Macrophage extracellular traps require peptidylarginine deiminase 2 and 4 and are a source of citrullinated antigens bound by rheumatoid arthritis autoantibodies

المؤلفون: S. Janna Bashar, Caitlyn L. Holmes, Miriam A. Shelef

المصدر: Frontiers in Immunology, Vol 15 (2024)

مصطلحات موضوعية: macrophage extracellular trap, citrullinated antigens, anti-citrullinated protein antibodies, rheumatoid arthritis, peptidylarginine deiminase 2, peptidylarginine deiminase 4, Immunologic diseases. Allergy, RC581-607

وصف الملف: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fimmu.2024.1167362/full; https://doaj.org/toc/1664-3224

URL الوصول: https://doaj.org/article/775a57052f284fc39ce1d8353ef9387b

View record in DOAJ

Full Text Finder

12

Academic Journal

New-onset Seropositive Rheumatoid Arthritis Post-mRNA COVID-19 Vaccine: A Case Report

المؤلفون: manda Almouslem, Talal Al Lawati, Ali Al Shirawi, Usama Al Amri

المصدر: Oman Medical Journal, Vol 39, Iss 1, Pp e597-e597 (2024)

مصطلحات موضوعية: anti-citrullinated protein antibodies, covid-19, covid-19 vaccines, rna, messenger, arthritis, rheumatoid, Medicine

وصف الملف: electronic resource

Relation: https://omjournal.org/articleDetails.aspx?coType=1&aId=3614; https://doaj.org/toc/1999-768X; https://doaj.org/toc/2070-5204

URL الوصول: https://doaj.org/article/1bf59c26e75f4e3f8053f604800fbb89

View record in DOAJ

Full Text Finder

13

Academic Journal

Association of rheumatoid factor, anti-citrullinated protein antibodies and shared epitope with clinical response to initial treatment in patients with early rheumatoid arthritis:data from a randomised controlled trial

المصدر: Lend , K , Lampa , J , Padyukov , L , Hetland , M L , Heiberg , M S , Nordström , D C , Nurmohamed , M T , Rudin , A , Østergaard , M , Haavardsholm , E A , Hørslev-Petersen , K , Uhlig , T , Sokka-Isler , T , Gudbjornsson , B , Grondal , G , Frazzei , G , Christiaans , J , Wolbink , G , Rispens , T , Twisk , J W R & van Vollenhoven , R F 2024 , ' Association of rheumatoid factor, ....

مصطلحات موضوعية: Abatacept, Anti-Citrullinated Protein Antibodies, Arthritis, Rheumatoid, Biological Therapy, Rheumatoid Factor

وصف الملف: application/pdf

الاتاحة: https://researchprofiles.ku.dk/da/publications/association-of-rheumatoid-factor-anticitrullinated-protein-antibodies-and-shared-epitope-with-clinical-response-to-initial-treatment-in-patients-with-early-rheumatoid-arthritis(253d9823-1b3b-4016-a353-1015e9d70388).html
https://doi.org/10.1136/ard-2024-226024
https://curis.ku.dk/ws/files/413564336/1657.full.pdf

View record in BASE

14

Academic Journal

Comparative Effectiveness of Abatacept vs. Tofacitinib in Rheumatoid Arthritis Patients who are CCP

المؤلفون: Harrold, Leslie R, Wittstock, Keith, Kelly, Sheila, Han, Xue, Shan, Ying, Guo, Lin, Moore, Page C, Khaychuk, Vadim

المساهمون: Medicine

المصدر: Rheumatology and therapy ; 10 ; 3 ; 575 ; 587 ; England

مصطلحات موضوعية: Anti-citrullinated protein antibodies, Comparative effectiveness research, DMARD, Registries, Rheumatoid arthritis

Relation: Rheumatology and therapy; https://doi.org/10.1007/s40744-022-00523-z; http://hdl.handle.net/20.500.14038/53697

الاتاحة: https://doi.org/10.1007/s40744-022-00523-z
https://hdl.handle.net/20.500.14038/53697

View record in BASE

15

Academic Journal

Association of rheumatoid factor, anti-citrullinated protein antibodies and shared epitope with clinical response to initial treatment in patients with early rheumatoid arthritis : data from a randomised controlled trial

المساهمون: HUS Internal Medicine and Rehabilitation, Department of Medicine, Clinicum, University of Helsinki

مصطلحات موضوعية: Abatacept, Anti-Citrullinated Protein Antibodies, Arthritis, Rheumatoid, Biological Therapy, Rheumatoid Factor, General medicine, internal medicine and other clinical medicine

وصف الملف: application/pdf

Relation: We express our gratitude to the patients, study nurses, investigators, joint assessors, data management and study teams who were involved in the NORD-STAR trial. The NORD-STAR trial was funded through the following public sources: the Academy of Finland (grant number 258536); Finska L\u00E4kares\u00E4llskapet; a grant from the South-Eastern Health Regional Health Authority, Norway; a Helsinki University Central Hospital (HUCH) institutional grant, Finland (grant number 1159005); the Icelandic Society for Rheumatology; an inter-regional grant from all health regions in Norway; NordForsk (grant number 70945); Regionernes Medicinpulje, Denmark (grant number 14/217); Stockholm County Council, Sweden (grant number 20100490); the Swedish Medical Research Council (grant numbers C0634901, D0342301, 2015-00891_5); the Swedish Rheumatism Association; and The Research Fund of University Hospital, Reykjavik, Iceland (A2015017). UCB provided certolizumab pegol at no cost. Bristol Myers Squibb provided abatacept at no cost. Additionally, the Karolinska Institute received several unrestricted grants from Bristol Myers Squibb; these were subsequently transferred to the principal investigators of Denmark, Finland and the Netherlands to help defray various trial related costs at the local level. Part of this work has been presented at the EULAR - Annual European Congress of Rheumatology 2024 in Vienna. LP reports institutional support for the present manuscript from Amsterdam University Medical Centers. MLH reports institutional grants from AbbVie, Bristol Myers Squibb, Eli Lilly, MSD, Pfizer, Sandoz, Novartis, Nordforsk and UCB; speaker honoraria from Medac, Novartis, Pfizer, Sandoz and UCB; institutional data safety monitoring board or advisory board fees from AbbVie. MLH has chaired the steering committee of the Danish Rheumatology Quality Registry (DANBIO, DRQ), which receives public funding from the hospital owners and funding from pharmaceutical companies. MLH co-chairs EuroSpA, which generates real-world evidence of treatment of psoriatic arthritis and axial spondyloarthritis based on secondary data and is partly funded by Novartis and UCB. DCN reports research grant from MSD; consulting fees from Bristol Myers Squibb, Lilly, Novartis, Pfizer, and UCB; speaker honoraria from Pfizer and UCB; participation on a data safety monitoring board or advisory board fees from UCB. M\u00D8 reports institutional grants from AbbVie, Amgen, Bristol Myers Squibb, Merck, Celgene, Eli Lilly Novartis and UCB; personal speaker honoraria from AbbVie, Bristol Myers Squibb, Boehringer-Ingelheim, Celgene, Eli Lilly, Galapagos, Gilead, Hospira, Janssen, MEDAC, Merck, Novartis, Novo, Orion, Pfizer, Regeneron, Roche, Sandoz, Sanofi and UCB; participation on a data safety monitoring board or advisory board personal fees from AbbVie, Bristol Myers Squibb, Boehringer-Ingelheim, Celgene, Eli Lilly, Galapagos, Gilead, Hospira, Janssen, MEDAC, Merck, Novartis, Novo, Orion, Pfizer, Regeneron, Roche, Sandoz, Sanofi and UCB. EAH reports institutional grant from research council of Norway; personal speaker honoraria from Pfizer, UCB and Novartis; and participation on a data safety monitoring board or advisory board fees from AbbVie, Pfizer and Eli Lilly. TU reports personal speaker honoraria from Lilly, Pfizer, UCB and Galapagos. TR reports a patent application (TR is the inventor) based on the use of bioengineered IgG targets for the characterisation of rheumatoid factor reactivity patterns. RFvV reports institutional support for the present manuscript from Bristol Myers Squibb; institutional grants for research or education from Alfasigma, AstraZeneca, Bristol Myers Squibb, Galapagos, MSD, Novartis, Pfizer, Roche, Sanofi and UCB; consulting fees from AbbVie, AstraZeneca, Biogen, Bristol Myers Squibb, Galapagos, GSK, Janssen, Pfizer, RemeGen and UCB; speaker honoraria from AbbVie, AstraZeneca, Bristol Myers Squibb, Galapagos, GSK, Janssen, Pfizer and UCB; and participation on a data safety monitoring board or advisory board fees from AbbVie, AstraZeneca, Biogen, Bristol Myers Squibb, Galapagos, GSK, Janssen, Pfizer, RemeGen and UCB. All other authors declare no competing interests.; Lend , K , Lampa , J , Padyukov , L , Hetland , M L , Heiberg , M S , Nordström , D C , Nurmohamed , M T , Rudin , A , Østergaard , M , Haavardsholm , E A , Hørslev-Petersen , K , Uhlig , T , Sokka-Isler , T , Gudbjornsson , B , Grondal , G , Frazzei , G , Christiaans , J , Wolbink , G , Rispens , T , Twisk , J W R & Van Vollenhoven , R F 2024 , ' Association of rheumatoid factor, anti-citrullinated protein antibodies and shared epitope with clinical response to initial treatment in patients with early rheumatoid arthritis : data from a randomised controlled trial ' , Annals of the Rheumatic Diseases . https://doi.org/10.1136/ard-2024-226024; http://hdl.handle.net/10138/584533; dd70d296-e2af-41f9-8e67-777c269d8c00; 85200457055; 001280782900001

الاتاحة: http://hdl.handle.net/10138/584533

View record in BASE

16

Academic Journal

Factors associated with resolution of ultrasound subclinical synovitis in anti-CCP-positive individuals with musculoskeletal symptoms:a UK prospective cohort study

المؤلفون: Garcia-Montoya, Leticia, Kang, Jing, Duquenne, Laurence, Di Matteo, Andrea, Nam, Jacqueline L, Harnden, Kate, Chowdhury, Rahaymin, Mankia, Kulveer, Emery, Paul

المصدر: Garcia-Montoya , L , Kang , J , Duquenne , L , Di Matteo , A , Nam , J L , Harnden , K , Chowdhury , R , Mankia , K & Emery , P 2024 , ' Factors associated with resolution of ultrasound subclinical synovitis in anti-CCP-positive individuals with musculoskeletal symptoms : a UK prospective cohort study ' , The Lancet Rheumatology , vol. 6 , no. 2 , pp. e72-e80 . https://doi.org/10.1016/S2665-9913(23)00305-3 , https://doi.org/10.1016/S2665-9913(23)00305-3

مصطلحات موضوعية: Male, Humans, Female, Middle Aged, Anti-Citrullinated Protein Antibodies, Prospective Studies, Cohort Studies, Arthritis, Rheumatoid, Autoantibodies, United Kingdom/epidemiology

Relation: https://kclpure.kcl.ac.uk/portal/en/publications/10f2835b-b60c-4051-a0c4-a740ed50fe74

الاتاحة: https://kclpure.kcl.ac.uk/portal/en/publications/10f2835b-b60c-4051-a0c4-a740ed50fe74
https://doi.org/10.1016/S2665-9913(23)00305-3
http://www.scopus.com/inward/record.url?scp=85183057876&partnerID=8YFLogxK

View record in BASE

17

Academic Journal

Antigen-specific Fab profiling achieves molecular-resolution analysis of human autoantibody repertoires in rheumatoid arthritis

المؤلفون: Stork, Eva Maria, van Rijswijck, Danique M H, van Schie, Karin A, Hoek, Max, Kissel, Theresa, Scherer, Hans Ulrich, Huizinga, Tom W J, Heck, Albert J R, Toes, Rene E M, Bondt, Albert

المساهمون: Afd Biomol.Mass Spect. and Proteomics, Sub Biomol.Mass Spectrometry & Proteom., Biomolecular Mass Spectrometry and Proteomics

مصطلحات موضوعية: Anti-Citrullinated Protein Antibodies, Arthritis, Rheumatoid, Autoantibodies, Autoantigens, Humans, Immunoglobulin G

وصف الملف: application/pdf

Relation: https://dspace.library.uu.nl/handle/1874/438266

الاتاحة: https://dspace.library.uu.nl/handle/1874/438266

View record in BASE

Full Text Finder

18

Academic Journal

Polyautoimmunity in patients with anti-cyclic citrullinated peptide antibody-positive and -negative rheumatoid arthritis: a nationwide cohort study from Denmark

المؤلفون: Kristensen, Salome, Hagelskjær, Amalie Made, Cordtz, René, Bliddal, Sofie, Mortensen, Anders Sandermann, Nielsen, Claus Henrik, Feldt-Rasmussen, Ulla, Lauridsen, Karen Buch, Dreyer, Lene

المصدر: Kristensen , S , Hagelskjær , A M , Cordtz , R , Bliddal , S , Mortensen , A S , Nielsen , C H , Feldt-Rasmussen , U , Lauridsen , K B & Dreyer , L 2024 , ' Polyautoimmunity in patients with anti-cyclic citrullinated peptide antibody-positive and -negative rheumatoid arthritis: a nationwide cohort study from Denmark ' , Journal of Rheumatology , vol. 51 , no. 4 , jrheum.2023-0907 , pp. 350-359 . https://doi.org/10.3899/jrheum.2023-0907

مصطلحات موضوعية: Anti-Citrullinated Protein Antibodies, Arthritis, Rheumatoid/diagnosis, Autoantibodies, Cohort Studies, Denmark/epidemiology, Humans, Peptides, Cyclic